• 1. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Application of Ethyl 6-bromo-5-methylpicolinate (CAS: 1807149-82-1) in Chemical Biology and Pharmaceutical Research

Ethyl 6-bromo-5-methylpicolinate (CAS: 1807149-82-1) has emerged as a pivotal intermediate in the synthesis of bioactive molecules, particularly in the development of kinase inhibitors and other therapeutic agents. Recent studies have highlighted its utility in medicinal chemistry due to its unique structural features, which enable efficient derivatization and functionalization. This research brief consolidates the latest findings on the applications, synthetic methodologies, and pharmacological potential of this compound, providing a comprehensive overview for researchers in the field.

One of the most significant advancements involves the use of Ethyl 6-bromo-5-methylpicolinate as a building block in the synthesis of novel pyridine-based kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its role in the development of selective JAK2 inhibitors, which show promise for treating myeloproliferative disorders. The bromo and ester functional groups in the compound facilitate Suzuki-Miyaura cross-coupling reactions, enabling the introduction of diverse aryl and heteroaryl substituents. This versatility has been leveraged to optimize drug-like properties such as solubility and metabolic stability.

In addition to its applications in kinase inhibitor development, recent research has explored the compound's potential in antimicrobial drug discovery. A team at the University of Cambridge reported in Bioorganic & Medicinal Chemistry Letters (2024) that derivatives of Ethyl 6-bromo-5-methylpicolinate exhibited potent activity against drug-resistant Gram-positive bacteria, with MIC values in the low micromolar range. The presence of the methyl group at the 5-position was found to be crucial for maintaining antibacterial activity while reducing cytotoxicity against mammalian cells.

The synthetic accessibility of Ethyl 6-bromo-5-methylpicolinate has also been improved through recent methodological developments. A 2024 publication in Organic Process Research & Development described a scalable, one-pot procedure for its synthesis from commercially available 5-methylpicolinic acid, achieving an overall yield of 78% with excellent purity (>99%). This advancement addresses previous challenges in large-scale production, making the compound more accessible for drug discovery programs.

From a mechanistic perspective, computational studies have provided insights into the molecular interactions of Ethyl 6-bromo-5-methylpicolinate derivatives with biological targets. Molecular docking simulations published in RSC Advances (2023) revealed that the picolinate scaffold maintains optimal hydrogen bonding patterns with key amino acid residues in various enzyme active sites, explaining the observed structure-activity relationships across different therapeutic targets.

Looking forward, the unique properties of Ethyl 6-bromo-5-methylpicolinate position it as a valuable tool in chemical biology. Its applications extend beyond drug discovery to include the development of chemical probes for target identification and validation. As research continues to uncover new applications for this versatile building block, its importance in medicinal chemistry is expected to grow significantly in the coming years.

• 26218-75-7(Methyl 6-bromopyridine-2-carboxylate)
• 21190-88-5(Ethyl 6-Bromopicolinate)
• 1079947-40-2(Ethyl 1-bromoisoquinoline-3-carboxylate)
• 934-07-6(Methyl 5-bromo-1H-pyrrole-2-carboxylate)
• 1209093-48-0(Methyl 6-bromo-5-methylpicolinate)
• 910044-07-4(tert-butyl 6-bromopyridine-2-carboxylate)
• 110814-85-2(1H-Pyrrole-2-carboxylic acid, 5-bromo-3,4-dimethyl-, ethyl ester)
• 1211516-25-4(6-bromo-5-methyl-pyridine-2-carboxylic acid)
• 740813-37-0(Ethyl 5-bromo-1H-pyrrole-2-carboxylate)
• 250674-54-5(Ethyl 1-bromo-2,7-naphthyridine-3-carboxylate)